Treatment of bacterial complications of infectious mononucleosis in children in an outpatient setting

Abstract

The choice of antibiotic drug for purulent complications of infectious mononucleosis in children in an outpatient setting is limited by the requirement for oral administration. The clinical observation showed that antibiotic therapy with Sumamed® is comparable with cephalexin in terms of efficacy but has a higher safety profile. Broad-spectrum antimicrobial activity of Sumamed®, lowest-frequency administration and lowest duration of the course may increase patients' adherence to antibiotic therapy.